ISPC vs REG · rev $9.3M vs P/E 34, $12.93B cap
iSpecimen Inc (ISPC) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
REG does not have a complete income-statement cache yet.
ISPC currently screens at market cap $4.4M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the ISPC and REG stock pages for the full models.
Not investment advice.